cas 69998-14-7|| where to buy 1-Isopropylpyrimidine-2,4,6(1H,3H,5H)-trione

Nombre del producto:1-Isopropylpyrimidine-2,4,6(1H,3H,5H)-trione

IUPAC Name:1-(propan-2-yl)-1,3-diazinane-2,4,6-trione

Unidad de embalaje	Stock disponible	Precio($)
CM337821-100mg	in stock	ǶǶǜ
CM337821-250mg	in stock	ȺǜǶ
CM337821-1g	in stock	Ǌȡũ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 69998-14-7 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :69998-14-7; Fórmula molecular:C7H10N2O3; Punto de fusión:-; Código de sonrisas:O=C1NC(CC(N1C(C)C)=O)=O; Densidad:

: Número de catálogo:CM337821; Peso molecular:170.17; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

: Mavacamten; CAMZYOS(Mavacamten) was recently approved in the European Union, following its approval in the U.S. and other markets worldwide, and is the first and only cardiac myosin inhibitor approved to treat adult patients with symptomatic obstructive hypertrophic cardiomyopathy(HCM).
Mavacamten is a first-in-class, targeted inhibitor of cardiac myosin, reduces the number of myosin-actin cross-bridges and thus decreases excessive contractility characteristic of HCM.